Myeloma Drug Pomalidomide Halts Severe Nosebleeds in Inherited Vascular Disease
A Japanese case report describes how the myeloma drug pomalidomide rapidly relieved transfusion-dependent nosebleeds in a patient with hereditary hemorrhagic ...
A Japanese case report describes how the myeloma drug pomalidomide rapidly relieved transfusion-dependent nosebleeds in a patient with hereditary hemorrhagic ...
A new Cell Death Discovery study shows that the two strands of the pre-miR-16-1 microRNA duplex can cooperatively suppress both ...
A real-world study of 214 patients finds that adding Bevacizumab to Olaparib maintenance therapy significantly improves overall survival only in ...
A sweeping review details how immune checkpoint inhibitors, combination regimens, CAR-T cells, vaccines, and oncolytic viruses are transforming treatment of ...
A phase II trial found that neoadjuvant camrelizumab plus apatinib, a chemotherapy-free combination of immunotherapy and anti-angiogenic therapy, produced manageable ...
A phase 2a trial found that surufatinib combined with PD-1/PD-L1 inhibitors as first-line maintenance therapy yielded a median progression-free survival ...
A real-world study of 87 patients suggests that combining Trop-2 antibody-drug conjugates with PD-1 inhibitors and anti-angiogenic therapy substantially improves ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine